Key facts
- Kayak Therapeutics’s last known valuation is $11.0M (Sep 2025).
- It has raised $6.6M across 2 recorded rounds; the latest was Early Stage VC ($11.9M) in May 2026.
- Kayak Therapeutics has filed 2 Form Ds with the SEC since 2025, most recently May 2026 ($11.9M sold to 55 investors).
- Status: Privately Held (backing).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·Watchlist + deal alerts for Kayak Therapeutics
Create free account
No card required
Funding rounds
2 roundsAbout Kayak Therapeutics
The company is currently operating in Stealth mode.
- Sector
- Healthcare
- HQ
- Austin, TX, United States
- Founded
- 2025
- Employees
- 4
- Website
- kayaktherapeutics.com/
- Ownership
- Privately Held (backing)
PA Mark — not yet priced
Kayak Therapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Kayak Therapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Kayak Therapeutics in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.